JP2006506074A5 - - Google Patents

Download PDF

Info

Publication number
JP2006506074A5
JP2006506074A5 JP2004552240A JP2004552240A JP2006506074A5 JP 2006506074 A5 JP2006506074 A5 JP 2006506074A5 JP 2004552240 A JP2004552240 A JP 2004552240A JP 2004552240 A JP2004552240 A JP 2004552240A JP 2006506074 A5 JP2006506074 A5 JP 2006506074A5
Authority
JP
Japan
Prior art keywords
cell line
hcv rna
genomic
subgenomic
hcv
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2004552240A
Other languages
English (en)
Japanese (ja)
Other versions
JP2006506074A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2003/036634 external-priority patent/WO2004044182A2/en
Publication of JP2006506074A publication Critical patent/JP2006506074A/ja
Publication of JP2006506074A5 publication Critical patent/JP2006506074A5/ja
Pending legal-status Critical Current

Links

JP2004552240A 2002-11-13 2003-11-13 C型肝炎ウイルスの複製に対して高許容性である細胞系 Pending JP2006506074A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42625602P 2002-11-13 2002-11-13
PCT/US2003/036634 WO2004044182A2 (en) 2002-11-13 2003-11-13 Highly permissive cell lines for hepatitis c virus replication

Publications (2)

Publication Number Publication Date
JP2006506074A JP2006506074A (ja) 2006-02-23
JP2006506074A5 true JP2006506074A5 (https=) 2006-04-06

Family

ID=32313126

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2004552240A Pending JP2006506074A (ja) 2002-11-13 2003-11-13 C型肝炎ウイルスの複製に対して高許容性である細胞系

Country Status (8)

Country Link
US (1) US7455969B2 (https=)
EP (1) EP1578956A4 (https=)
JP (1) JP2006506074A (https=)
CN (1) CN1711352A (https=)
AU (1) AU2003294292A1 (https=)
CA (1) CA2505551A1 (https=)
MX (1) MXPA05005092A (https=)
WO (1) WO2004044182A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7794942B2 (en) * 1997-03-04 2010-09-14 Washington University Cell lines permissive for HCV replication
US7790448B2 (en) 2003-09-19 2010-09-07 Tokyo Metropolitan Organization For Medical Research Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene
CA2539457C (en) 2003-09-19 2013-12-03 Tokyo Metropolitan Organization For Medical Research Nucleic acid and gene derived from novel hcv strain and replicon-replicating cell using said gene
US7659103B2 (en) * 2004-02-20 2010-02-09 Tokyo Metropolitan Organization For Medical Research Nucleic acid construct containing fulllength genome of human hepatitis C virus, recombinant fulllength virus genome-replicating cells having the nucleic acid construct transferred thereinto and method of producing hepatitis C virus Particle
US7919242B2 (en) 2005-06-30 2011-04-05 Roche Molecular Systems, Inc. Light emission modifiers and their uses in nucleic acid detection, amplification and analysis
EP1909564A4 (en) 2005-07-18 2010-06-30 Novartis Ag SMALL ANIMAL MODEL FOR HCV REPLICATION
EP1910522A2 (en) * 2005-07-18 2008-04-16 Novartis Vaccines and Diagnostics S.r.l. Caveolin-3 and in vitro culture of hepatitis c virus
JP5035985B2 (ja) * 2005-09-30 2012-09-26 国立感染症研究所長 新規組換え型ヒトc型肝炎ウイルス様粒子とその産生方法
US7504255B2 (en) * 2006-08-17 2009-03-17 Saint Louis University Compositions and methods for generation of infectious hepatitis C virus in immortalized human hepatocytes
ITMI20061772A1 (it) * 2006-09-18 2008-03-19 Consiglio Nazionale Ricerche Procedimento per la preparazione di cellule epatiche da cellule progenitrici presenti nel sangue di cordone ombelicale
CA2748357A1 (en) * 2008-12-26 2010-07-01 Takaji Wakita Nucleic acid derived from hepatitis c virus and expression vector, transformed cell, and hepatitis c virus particles each prepared by using the same
CA2780079A1 (en) * 2009-11-18 2011-05-26 Basf Plant Science Company Gmbh Process for the production of fine chemicals
KR102089477B1 (ko) 2012-08-31 2020-03-17 더 가버너스 오브 더 유니버시티 오브 알버타 1차 인간 간세포의 표현형을 갖는 세포를 생성하기 위한 방법 및 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
DE19915178A1 (de) * 1999-04-03 2000-10-05 Univ Mainz Johannes Gutenberg Hepatitis C Virus Zellkultursystem
DK1296998T3 (da) * 2000-05-23 2011-12-12 Univ Washington HCV-varianter
EP1423522A2 (en) * 2001-01-23 2004-06-02 Istituto Di Ricerche Di Biologia Molecolare P. Angeletti S.P.A. Hepatitis c virus replicons and replicon enhanced cells
GB0114629D0 (en) 2001-06-15 2001-08-08 Pfizer Ltd Method

Similar Documents

Publication Publication Date Title
JP2006506074A5 (https=)
Yu et al. Phylogenetics, genomic recombination, and NSP2 polymorphic patterns of porcine reproductive and respiratory syndrome virus in China and the United States in 2014–2018
Gehrke et al. Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line
Huang et al. Initiation at the third in-frame AUG codon of open reading frame 3 of the hepatitis E virus is essential for viral infectivity in vivo
Kim et al. Whole-genome sequencing and genetic characteristics of representative porcine reproductive and respiratory syndrome virus (PRRSV) isolates in Korea
Kofler et al. Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C
Verheije et al. Kissing interaction between 3′ noncoding and coding sequences is essential for porcine arterivirus RNA replication
IL176731A (en) Method for producing a cell line permissive for hcv replication and a cell line produced by said method
Harasawa et al. A novel method for pestivirus genotyping based on palindromic nucleotide substitutions in the 5′-untranslated region
EP1721985A4 (en) Nucleic acid construct containing full-length genome of human hepatitis c virus, recombinant full-length virus genome replicative cell having the nucleic acid construct transferred thereinto and method of constructing hepatitis c viral particles
Koh et al. Sustained Wolbachia-mediated blocking of dengue virus isolates following serial passage in Aedes aegypti cell culture
Sui et al. Genomic sequence and virulence of a novel NADC30-like porcine reproductive and respiratory syndrome virus isolate from the Hebei province of China
Keep et al. Deletion of the s2m RNA structure in the avian coronavirus infectious bronchitis virus and human astrovirus results in sequence insertions
JP2003533232A5 (https=)
Oleksiewicz et al. Determination of 5′-leader sequences from radically disparate strains of porcine reproductive and respiratory syndrome virus reveals the presence of highly conserved sequence motifs
Choi et al. Identification of 5′ and 3′ cis-acting elements of the porcine reproductive and respiratory syndrome virus: acquisition of novel 5′ AU-rich sequences restored replication of a 5′-proximal 7-nucleotide deletion mutant
WO2011039639A3 (en) Jfh-1 based hcv cell culture systems for ns5a of genotypes 1-7
Zhu et al. Attenuated dengue 2 viruses with deletions in capsid protein derived from an infectious full-length cDNA clone
JPWO2022019306A5 (https=)
Pascalis et al. Complete genome sequences of dengue virus type 2 epidemic strains from Reunion Island and the Seychelles
Zhang et al. Persistent equine arteritis virus infection in HeLa cells
Li et al. Non-genotype-specific role of the hepatitis C virus 5′ untranslated region in virus production and in inhibition by interferon
Gallei et al. Noncytopathogenic pestivirus strains generated by nonhomologous RNA recombination: alterations in the NS4A/NS4B coding region
CN101285054A (zh) 稳定表达t7 rna聚合酶的st细胞系及其构建方法和应用
US8022197B2 (en) Nucleic acid and gene derived from novel HCV strain and replicon-replicating cell using said gene